Smooth muscle cells improve endothelial cell retention on polytetrafluoroethylene grafts in vivo

Journal of Vascular Surgery

Volumn 38, Issue 3, 2003, Pages 557-563

  Yu, Hong ^a   Dai, Wangde ^b   Yang, Zhe ^a   Kirkman, Paul ^b   Weaver, Fred A ^b   Eton, Darwin ^a   Rowe, Vincent L ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; IN VIVO STUDY; INTIMA; NONHUMAN; POLITEF IMPLANT; PRIORITY JOURNAL; RABBIT; SHUNTING; SMOOTH MUSCLE FIBER; ANIMAL; BLOOD FLOW VELOCITY; BLOOD VESSEL PROSTHESIS; COMPARATIVE STUDY; CYTOLOGY; GRAFT OCCLUSION; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROBABILITY; PROSTHESIS; PROSTHESIS FAILURE; SENSITIVITY AND SPECIFICITY; TRANSPLANTATION; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM; VASCULAR PATENCY; VASCULAR SMOOTH MUSCLE;

POLITEF;

ANIMALS; BLOOD FLOW VELOCITY; BLOOD VESSEL PROSTHESIS; ENDOTHELIUM, VASCULAR; GRAFT OCCLUSION, VASCULAR; IMMUNOHISTOCHEMISTRY; MODELS, ANIMAL; MUSCLE, SMOOTH, VASCULAR; POLYTETRAFLUOROETHYLENE; PROBABILITY; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RABBITS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; TUNICA INTIMA; VASCULAR PATENCY;

EID: 0141724513     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(03)00334-3     Document Type: Article

References (35)

1. Herring M, Gardner A, Glover J. A single-staged technique for seeding vascular grafts with autogenous endothelium. Surgery 1978;84:498-504.
2. Eickhoff JH, Broome A, Ericsson BF, Buchardt Hansen HJ, Kordt KF, Mouritzen C, et al. Four years' results of a prospective, randomized clinical trial comparing polytetrafluoroethylene and modified human umbilical vein for below-knee femoropopliteal bypass. J Vasc Surg 1987;6:506-11.
3. Pearce WH, Rutherford RB, Whitehill TA, Rosales C, Bell KP, Patt A, et al. Successful endothelial seeding with omentally derived microvascular endothelial cells. J Vasc Surg 1987;5:203-6.
4. Shindo S, Takagi A, Whittemore AD. Improved patency of collagen-impregnated grafts after in vitro autogenous endothelial cell seeding. J Vasc Surg 1987;6:325-32.
5. Deutsch M, Meinhart J, Fischlein T, Preiss P, Zilla P. Clinical autologous in vitro endothelialization of infrainguinal ePTFE grafts in 100 patients: a 9-year experience. Surgery 1999;126:847-55.
6. Jensen N, Lindblad B, Bergqvist D. Endothelial cell seeded dacron aortobifurcated grafts: platelet deposition and long-term follow-up. J Cardiovasc Surg 1994;35:425-9.
7. Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 1996;84:345-57.
8. Kaehler J, Zilla P, Fasol R, Deutsch M, Kadletz M. Precoating substrate and surface configuration determine adherence and spreading of seeded endothelial cells on polytetrafluoroethylene grafts. J Vasc Surg 1989;9: 535-41.
9. Falk J, Townsend LE, Vogel M, Boyer M, Olt S, Wease GL, et al. Improved adherence of genetically modified endothelial cells to small-diameter expanded polytetrafluoroethylene grafts in a canine model. J Vasc Surg 1998;27:902-9.
10. Clowes MM, Lynch CM, Miller AD, Miller DG, Osborne WR, Clowes AW. Long-term biological response of injured rat carotid artery seeded with smooth muscle cells expressing retrovirally introduced human genes. J Clin Invest 1994;93:644-51.
11. Geary RL, Clowes AW, Lau S, Vergel S, Dale DC, Osborne WR. Gene transfer in baboons using prosthetic vascular grafts seeded with retrovirally transduced smooth muscle cells: a model for local and systemic gene therapy. Hum Gene Ther 1994;5:1211-6.
12. Bhat VD, Truskey GA, Reichert WM. Fibronectin and avidin-biotin as a heterogeneous ligand system for enhanced endothelial cell adhesion. J Biomed Mater Res 1998;41:377-85.
13. Shayani V, Newman KD, Dichek DA. Optimization of recombinant t-PA secretion from seeded vascular grafts. J Surg Res 1994;57:495-504.
14. Dunn PF, Newman KD, Jones M, Yamada I, Shayani V, Virmani R, et al. Seeding of vascular grafts with genetically modified endothelial cells: secretion of recombinant TPA results in decreased seeded cell retention in vitro and in vivo [see comments]. Circulation 1996;93:1439-46.
15. Yu H, Wang Y, Eton D, Rowe VL, Terramani TT, Cramer DV, et al. Dual cell seeding and the use of zymogen tissue plasminogen activator to improve cell retention on polytetrafluoroethylene grafts. J Vasc Surg 2001;34:337-43.
16. Huber TS, Welling TH, Sarkar R, Messina LM, Stanley JC. Effects of retroviral-mediated tissue plasminogen activator gene transfer and expression on adherence and proliferation of canine endothelial cells seeded onto expanded polytetrafluoroethylene. J Vasc Surg 1995;22: 795-803.
17. Kimura H, Sakata Y, Hamada H, Yoshida Y, Sato O, Deguchi J, et al. In vivo retention of endothelial cells adenovirally transduced with tissue-type plasminogen activator and seeded onto expanded polytetrafluoroethylene. J Vasc Surg 2000;32:353-63.
18. Dichek DA, Anderson J, Kelly AB, Hanson SR, Harker LA. Enhanced in vivo antithrombotic effects of endothelial cells expressing recombinant plasminogen activators transduced with retroviral vectors. Circulation 1996;93:301-9.
19. Yu H, Wang Y, Eton D, Stins M, Wang L, Apuzzo ML, et al. Retroviral vector-mediated transfer and expression of human tissue plasminogen activator cDNA in bovine brain endothelial cells [in process citation]. Neurosurgery 1999;45:962-8; discussion 968-70.
20. Eton D, Terramani TT, Wang Y, Takahashi AM, Nigro JJ, Tang L, et al. Genetic engineering of stent grafts with a highly efficient pseudotyped retroviral vector. J Vasc Surg 1999;29:863-73.
21. Dewey CF Jr, editor. Fluid mechanics of arterial flow. New York, NY: Plenum, 1979.
22. Gomes D, Louedec L, Plissonnier D, Dauge MC, Henin D, Osborne-Pellegrin M, et al. Endoluminal smooth muscle cell seeding limits intimal hyperplasia. J Vasc Surg 2001;34:707-15.
23. Yu H, Eton D, Wang Y, Kumar S, Tang L, Terramani T, et al. High efficiency in vitro gene transfer into vascular tissues using a pseudotyped retroviral vector without pseudotransduction. Gene Ther 1999;6:1876-83.
24. Schneider PA, Hanson SR, Price TM, Harker LA. Preformed confluent endothelial cell monolayers prevent early platelet deposition on vascular prostheses in baboons. J Vasc Surg 1988;8:229-35.
25. Fillinger MF, O'Connor SE, Wagner RJ, Cronenwett JL. The effect of endothelial cell coculture on smooth muscle cell proliferation. J Vasc Surg 1993;17:1058-67 discussion 1067-8.
26. Powell RJ, Cronenwett JL, Fillinger MF, Wagner RJ, Sampson LN. Endothelial cell modulation of smooth muscle cell morphology and organizational growth pattern. Ann Vasc Surg 1996;10:4-10.
27. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-9.
28. Schleef RR, Podor TJ, Dunne E, Mimuro J, Loskutoff DJ. The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator. J Cell Biol 1990;110:155-63.
29. Lupu F, Bergonzelli GE, Heim DA, Cousin E, Genton CY, Bachmann F, et al. Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries. Arterioscler Thromb 1993;13:1090-100.
30. Redmond EM, Cullen JP, Cahill PA, Sitzmann JV, Stefansson S, Lawrence DA, et al. Endothelial cells inhibit flow-induced smooth muscle cell migration: role of plasminogen activator inhibitor-1. Circulation 2001;103:597-603.
31. Proia RR, Nelson PR, Mulligan-Kehoe MJ, Wagner RJ, Kehas AJ, Powell RJ. The effect of endothelial cell overexpression of plasminogen activator inhibitor-1 on smooth muscle cell migration. J Vasc Surg 2002;36:164-71.
32. von der Leyen HE, Gibbons GH, Morishita R, Lewis NP, Zhang L, Nakajima M, et al. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A 1995;92:1137-41.
33. Witzenbichler B, Kureishi Y, Luo Z, Le Roux A, Branellec D, Walsh K. Regulation of smooth muscle cell migration and integrin expression by the Gax transcription factor. J Clin Invest 1999;104:1469-80.
34. Cantelmo NL, Quist WC, Lo Gerfo FW. Quantitative analysis of anastomotic intimal hyperplasia in paired Dacron and PTFE grafts. J Cardiovasc Surg (Torino) 1989;30:910-5.
35. Sottiurai VS, Yao JS, Batson RC, Sue SL, Jones R, Nakamura YA. Distal anastomotic intimal hyperplasia: histopathologic character and biogenesis. Ann Vasc Surg 1989;3:26-33.